Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Vasc Med. 2014 Feb;19(1):33–41. doi: 10.1177/1358863X14520869

Table 3.

Hazard ratios (95% CIs) for venous thromboembolism according to categories of Troponin T (TnT), LITE

ARIC

TnT Category 1 2 3 4 5 P-trend
Range (ng/L) < 3 3 to ≤ 5 5 to ≤ 8 8 to ≤ 13 ≥ 13

N 3252 2463 1928 1223 685
Total VTE
      N events 58 42 44 39 24
    Incidence rate per 1000 person-yrs 2.15 2.08 2.87 4.11 4.86
      Model 1 1.00 0.94 (0.63, 1.41) 1.26 (0.84, 1.91) 1.76 (1.13, 2.74) 2.09 (1.24, 3.51) 0.0007
      Model 2 1.00 0.92 (0.61, 1.38) 1.15 (0.75, 1.74) 1.40 (0.88, 2.22) 1.65 (0.95, 2.87) 0.04
      Model 3 1.00 1.02 (0.66, 1.57) 1.23 (0.78, 1.95) 1.39 (0.82, 2.35) 1.66 (0.87, 3.16) 0.08
  Unprovoked VTE
      N events 21 11 22 17 3
      Model 2 1.00 0.70 (0.33, 1.49) 1.69 (0.88, 3.27) 1.72 (0.81, 3.68) 0.64 (0.17, 2.32) 0.32
  Provoked VTE
      N events 37 31 22 22 21
      Model 2 1.00 1.02 (0.63, 1.66) 0.86 (0.50, 1.50) 1.23 (0.68, 2.21) 2.16 (1.15, 4.06) 0.06
        Model 2, not cancer related 1.00 1.45 (0.72, 2.93) 1.14 (0.51, 2.57) 1.75 (0.75, 4.09) 3.99 (1.70, 9.41) 0.007
        Model 2, cancer related 1.00 0.73 (0.37, 1.44) 0.66 (0.31, 1.42) 0.87 (0.38, 2.00) 1.03 (0.37, 2.82) 0.86

CHS

N 1463 594 742 687 636 P-trend
Total VTEa
      N events 41 11 33 25 28
    Incidence rate per 1000 person-yrs 2.74 1.86 4.67 4.03 6.11
      Model 1 1.00 0.65 (0.33, 1.26) 1.58 (0.98, 2.53) 1.25 (0.73, 2.13) 1.87 (1.09, 3.21) 0.01
      Model 2 1.00 0.60 (0.30, 1.20) 1.47 (0.90, 2.38) 1.14 (0.66, 1.96) 1.70 (0.97, 2.99) 0.05
      Model 3 1.00 0.56 (0.26, 1.20) 1.27 (0.73, 2.21) 0.98 (0.53, 1.82) 1.48 (0.78, 2.83) 0.74
  Unprovoked VTE
      N events 15 4 12 11 7
      Model 2 1.00 0.46 (0.13, 1.59) 1.29 (0.58, 2.91) 1.15 (0.48, 2.74) 0.93 (0.33, 2.61) 0.74
  Provoked VTE
      N events 26 7 21 14 21
      Model 2 1.00 0.69 (0.30, 1.59) 1.58 (0.86, 2.88) 1.11 (0.55, 2.24) 2.29 (1.17, 4.51) 0.03
        Model 2, not cancer related 1.00 0.78 (0.28, 2.13) 1.49 (0.69, 3.10) 0.95 (0.37, 2.42) 2.79 (1.22, 6.38) 0.04
        Model 2, cancer related 1.00 0.53 (0.12, 2.43) 1.73 (0.66, 4.56) 1.38 (0.47, 4.05) 1.51 (0.45, 5.11) 0.33

POOLED - ARIC + CHS

N 4715 3057 2670 1910 1321 P-trend
Total VTE
      N events 99 53 77 64 52
    Incidence rate per 1000 person-yrs 2.36 2.03 3.44 4.08 5.46
      Model 1 1.00 0.85 (0.61, 1.19) 1.36 (1.00, 1.86) 1.51 (1.07, 2.12) 1.98 (1.36, 2.87) <.0001
      Model 2 1.00 0.83 (0.59, 1.17) 1.25 (0.91, 1.72) 1.28 (0.90, 1.81) 1.70 (1.15, 2.51) 0.004
      Model 3 1.00 0.87 (0.61, 1.26) 1.22 (0.86, 1.73) 1.18 (0.80, 1.76) 1.63 (1.04, 2.56) 0.03
  Unprovoked VTE
      N events 36 15 34 28 10
      Model 2 1.00 0.61 (0.33, 1.15) 1.48 (0.89, 2.46) 1.41 (0.80, 2.48) 0.84 (0.38, 1.82) 0.37
  Provoked VTE
      N events 63 38 43 36 42
      Model 2 1.00 0.95 (0.63, 1.44) 1.11 (0.74, 1.67) 1.19 (0.76, 1.87) 2.27 (1.43, 3.59) 0.003

Model 1: Adjusted for age, sex, and race.

Model 2: Adjusted for Model 1 + diabetes status, BMI, eGFR and CRP.

Model 3: Adjusted for Model 2 + time-dependent censoring of CHD or heart failure during follow-up.

a

Three CHS events had missing data for TnT.